EXPRESS PUBLICATION
Coronary syndromes following aspirin withdrawal
A special risk for late stent thrombosis
Emile Ferrari, MD*,
Mustapha Benhamou, MD,
Pierre Cerboni, MD and
Baudouy Marcel, MD
Pasteur Hospital, Nice, France
Manuscript received October 4, 2004;
revised manuscript received November 10, 2004,
accepted November 20, 2004.
* Reprint requests and correspondence: Dr. Emile Ferrari, Cardiology Department, Pasteur Hospital, 30, Avenue de la voie Romaine, Nice, Alpes Maritimes 06200 (Email: ferrari.e{at}chu-nice.fr).
OBJECTIVES: We sought to determine whether aspirin withdrawal is an encountered situation in coronary disease patients who relapsed.
BACKGROUND: Despite the recognized benefits of aspirin in coronary disease, and because of the threat of bleeding or poor compliance, aspirin intake is sometimes stopped. It is not known whether withdrawal of aspirin can be harmful in coronary-disease patients.
METHODS: Between September 1999 and April 2002, a total of 1,236 patients hospitalized for acute coronary syndrome (ACS) were questioned in order to determine whether aspirin intake had been interrupted.
RESULTS: Fifty-one of these ACSs occurred within 1 month after aspirin withdrawal. This represents 4.1% of all coronary events but 13.3% of recurrences. Among those patients who relapsed, the incidence of ST-segment elevation ACS was higher in those who stopped aspirin when compared to the 332 patients who did not stop aspirin (39% vs. 18%; p = 0.001). Ten (20%) cases involved a thrombosis of an uncoated stent implanted on average 15.5 ± 6.5 months previously. Mean delay between aspirin withdrawal and the acute coronary event was 10 ± 1.9 days. Reasons for aspirin withdrawal included minor surgery in 7 cases, fibroscopy in 8 cases, dental treatment in 13 cases, bleeding in 3 cases, and patient non-compliance in 20 cases.
CONCLUSIONS: Our results support the hypothesis that aspirin withdrawal in coronary patients may represent a real risk for the occurrence of a new coronary event. Many cases involved late uncoated-stent thrombosis. Assessment of the exact incidence of coronary recurrences after aspirin withdrawal will need prospective studies.
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | CAD = coronary artery disease |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. D. O'Connor, A. J. Taylor, E. C. Williams, and T. C. Winter
Coagulation Concepts Update
Am. J. Roentgenol.,
December 1, 2009;
193(6):
1656 - 1664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Aguejouf, F. Eizayaga, V. Desplat, P. Belon, and C. Doutremepuich
Prothrombotic and Hemorrhagic Effects of Aspirin
Clinical and Applied Thrombosis/Hemostasis,
October 1, 2009;
15(5):
523 - 528.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nikolsky, G. W. Stone, A. J. Kirtane, G. D. Dangas, A. J. Lansky, B. McLaurin, A. M. Lincoff, F. Feit, J. W. Moses, M. Fahy, et al.
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
J. Am. Coll. Cardiol.,
September 29, 2009;
54(14):
1293 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Napenas, C. H.L. Hong, M. T. Brennan, S. L. Furney, P. C. Fox, and P. B. Lockhart
The Frequency of Bleeding Complications After Invasive Dental Treatment in Patients Receiving Single and Dual Antiplatelet Therapy
J Am Dent Assoc,
June 1, 2009;
140(6):
690 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Ormiston and P. W.S. Serruys
Bioabsorbable Coronary Stents
Circ Cardiovasc Interv,
June 1, 2009;
2(3):
255 - 260.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimura, T. Morimoto, Y. Nakagawa, T. Tamura, K. Kadota, H. Yasumoto, H. Nishikawa, Y. Hiasa, T. Muramatsu, T. Meguro, et al.
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Circulation,
February 24, 2009;
119(7):
987 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. O'Riordan, R. J. Margey, G. Blake, and P. R. O'Connell
Antiplatelet Agents in the Perioperative Period
Arch Surg,
January 1, 2009;
144(1):
69 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Mackinnon, E. Fraser, K. Simpson, J. G. Fox, and C. Geddes
Is it necessary to stop antiplatelet agents before a native renal biopsy?
Nephrol. Dial. Transplant.,
November 1, 2008;
23(11):
3566 - 3570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Newsome, M. A. Kutcher, and R. L. Royster
Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention
Anesth. Analg.,
August 1, 2008;
107(2):
552 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster
Coronary Artery Stents: II. Perioperative Considerations and Management
Anesth. Analg.,
August 1, 2008;
107(2):
570 - 590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Foley, S. Foley, T. Kinnaird, and R.A. Anderson
Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination
QJM,
June 1, 2008;
101(6):
425 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Douketis, P. B. Berger, A. S. Dunn, A. K. Jaffer, A. C. Spyropoulos, R. C. Becker, and J. Ansell
The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
299S - 339S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Goyal and S. R. Punnam
Adverse Events Associated With Stopping Clopidogrel After Acute Coronary Syndrome
JAMA,
May 28, 2008;
299(20):
2389 - 2389.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H Bhatt and T. H Hauser
Very Late Stent Thrombosis After Dual Antiplatelet Therapy Discontinuation in a Patient with a History of Acute Stent Thrombosis
Ann. Pharmacother.,
May 1, 2008;
42(5):
708 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Ho, E. D. Peterson, L. Wang, D. J. Magid, S. D. Fihn, G. C. Larsen, R. A. Jesse, and J. S. Rumsfeld
Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
JAMA,
February 6, 2008;
299(5):
532 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Bertrand
When and how to discontinue antiplatelet therapy
Eur. Heart J. Suppl.,
January 1, 2008;
10(suppl_A):
A35 - A41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Windecker and B. Meier
Late Coronary Stent Thrombosis
Circulation,
October 23, 2007;
116(17):
1952 - 1965.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth.,
September 1, 2007;
99(3):
316 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Holmes Jr, D. J. Kereiakes, W. K. Laskey, A. Colombo, S. G. Ellis, T. D. Henry, J. J. Popma, P. W.J.C. Serruys, T. Kimura, D. O. Williams, et al.
Thrombosis and Drug-Eluting Stents: An Objective Appraisal
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth.,
May 1, 2007;
98(5):
560 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Maree and D. J. Fitzgerald
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Circulation,
April 24, 2007;
115(16):
2196 - 2207.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ouattara, H. Bouzguenda, Y. Le Manach, P. Leger, A. Mercadier, P. Leprince, N. Bonnet, G. Montalescot, B. Riou, and P. Coriat
Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin
Eur. Heart J.,
April 12, 2007;
(2007)
ehm049v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camenzind, P. G. Steg, and W. Wijns
A Cause for Concern
Circulation,
March 20, 2007;
115(11):
1440 - 1455.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Serruys and J. Daemen
Late Stent Thrombosis: A Nuisance in Both Bare Metal and Drug-Eluting Stents
Circulation,
March 20, 2007;
115(11):
1433 - 1439.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pfisterer, H. P. Brunner-La Rocca, P. T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser, et al.
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents: An Observational Study of Drug-Eluting Versus Bare-Metal Stents
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2584 - 2591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G.L. Biondi-Zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro, F. Burzotta, L. Testa, I. Sheiban, and G. Sangiorgi
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
Eur. Heart J.,
November 2, 2006;
27(22):
2667 - 2674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Albaladejo, E. Marret, V. Piriou, and C.-M. Samama
Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force.
Br. J. Anaesth.,
October 1, 2006;
97(4):
580 - 582.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Collet and G. Montalescot
Premature withdrawal and alternative therapies to dual oral antiplatelet therapy
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_G):
G46 - G52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Spahn, S. J. Howell, A. Delabays, and P.-G. Chassot
Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis.
Br. J. Anaesth.,
June 1, 2006;
96(6):
675 - 677.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Ge, I Iakovou, J Cosgrave, P Agostoni, F Airoldi, G M Sangiorgi, I Michev, A Chieffo, M Montorfano, M Carlino, et al.
Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting
Heart,
March 1, 2006;
92(3):
371 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Maulaz, D. C. Bezerra, P. Michel, and J. Bogousslavsky
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy--Reply
Arch Neurol,
February 1, 2006;
63(2):
301 - 301.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Pijak
Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy
Arch Neurol,
February 1, 2006;
63(2):
300 - 301.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marret, J.-P. Collet, P. Albaladejo, and G. Montalescot
Thrombosis After Implantation of Drug-Eluting Stents
JAMA,
January 4, 2006;
295(1):
36 - 36.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sirvinskas, A. Veikutiene, P. Grybauskas, J. Cimbolaityte, A. Mongirdiene, V. Veikutis, and L. Raliene
Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery
Perfusion,
January 1, 2006;
21(1):
61 - 66.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
U. S. Tantry, K. P. Bliden, and P. A. Gurbel
Overestimation of Platelet Aspirin Resistance Detection by Thrombelastograph Platelet Mapping and Validation by Conventional Aggregometry Using Arachidonic Acid Stimulation
J. Am. Coll. Cardiol.,
November 1, 2005;
46(9):
1705 - 1709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Warning About Stopping Aspirin Therapy
Journal Watch Cardiology,
April 15, 2005;
2005(415):
3 - 3.
[Full Text]
|
 |
|
|